Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02389062 · ClinicalTrials.gov registry record · NA
Noninvasive Markers of Gluten Ingestion in Celiac Disease Patients
A NA study, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT02389062 is a NA study that has completed, run by Thomas Jefferson University. The registered enrollment target is 5 participants.
The verdict
NCT02389062, a NA study, has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This is a clinical trial to evaluate the sensitivity of noninvasive, novel markers of gluten ingestion in celiac disease patients who are following gluten free diet for at least a period of one year. These noninvasive markers may be helpful to monitor the silent intestinal damage, possibly resulting from the accidental consumption of gluten due to cross contamination of gluten free diet.
Interventions
- OTHER Administration of gluten( food /wheat protein) capsules or placebo(cornstarch) capsules and tests for novel markers will be done at intervals.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2015-02-11 |
| Est. Completion | 2017-02-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02389062
The ClinicalTrials.gov registry entry for NCT02389062 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Administration of gluten( food /wheat protein) capsules or placebo(cornstarch) capsules and tests for novel markers will be done at intervals. is the first listed.
NCT02389062 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02389062 about?
NCT02389062 is a clinical study titled "Noninvasive Markers of Gluten Ingestion in Celiac Disease Patients". This is a clinical trial to evaluate the sensitivity of noninvasive, novel markers of gluten ingestion in celiac disease patients who are following gluten free diet for at least a period of one year. These noninvasive markers may be helpful to monitor the silent intestinal damage, possibly resulting...
What is the current status of trial NCT02389062?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2015-02-11. Estimated completion is 2017-02-11.
What interventions are being tested in trial NCT02389062?
The interventions under investigation include: Administration of gluten( food /wheat protein) capsules or placebo(cornstarch) capsules and tests for novel markers will be done at intervals. (OTHER).
Who is sponsoring clinical trial NCT02389062?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.